🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 12/03/2015 | 0,4294 USD |
| 11/12/2014 | 0,4294 USD |
| 11/09/2014 | 0,4198 USD |
| 12/06/2014 | 0,4198 USD |
| 13/03/2014 | 0,4198 USD |
| 12/12/2013 | 0,4198 USD |
| 12/09/2013 | 0,4103 USD |
| 13/06/2013 | 0,4103 USD |
| 13/03/2013 | 0,4103 USD |
| 13/12/2012 | 0,4103 USD |
| 13/09/2012 | 0,4008 USD |
| 13/06/2012 | 0,4008 USD |
| 13/03/2012 | 0,4008 USD |
| 13/12/2011 | 0,4008 USD |
| 13/09/2011 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/06/2003 | 54,18 | 56,06 | 53,91 | 56,06 | +3,34% | 3,96% | 8.090.665 |
| 04/06/2003 | 53,61 | 54,50 | 53,39 | 54,25 | +0,98% | 2,08% | 5.130.379 |
| 03/06/2003 | 53,42 | 54,05 | 53,20 | 53,72 | +1,02% | 1,59% | 6.275.634 |
| 02/06/2003 | 53,24 | 53,75 | 53,08 | 53,18 | +0,27% | 1,25% | 6.622.941 |
| 30/05/2003 | 52,39 | 53,24 | 52,39 | 53,03 | +1,50% | 1,64% | 6.675.341 |
| 29/05/2003 | 53,19 | 53,80 | 52,15 | 52,25 | -1,76% | 3,10% | 7.721.874 |
| 28/05/2003 | 53,58 | 53,76 | 52,80 | 53,19 | -1,06% | 1,80% | 8.050.526 |
| 27/05/2003 | 52,65 | 53,93 | 52,24 | 53,76 | +1,60% | 3,21% | 7.178.800 |
| 23/05/2003 | 53,20 | 53,59 | 52,62 | 52,91 | -0,18% | 1,81% | 4.223.335 |
| 22/05/2003 | 52,62 | 53,49 | 52,39 | 53,01 | +0,31% | 2,10% | 6.705.209 |
| 21/05/2003 | 52,39 | 53,15 | 51,92 | 52,84 | +0,71% | 2,35% | 11.662.249 |
| 20/05/2003 | 53,53 | 53,70 | 51,62 | 52,47 | -2,93% | 3,89% | 14.915.660 |
| 19/05/2003 | 56,11 | 56,49 | 53,05 | 54,06 | -4,71% | 6,12% | 14.648.420 |
| 16/05/2003 | 56,52 | 56,92 | 56,11 | 56,73 | -0,13% | 1,43% | 4.419.311 |
| 15/05/2003 | 56,88 | 57,03 | 56,41 | 56,80 | -0,15% | 1,09% | 4.736.331 |
| 14/05/2003 | 56,87 | 57,14 | 56,39 | 56,89 | +0,49% | 1,31% | 5.186.552 |
| 13/05/2003 | 56,17 | 56,76 | 56,07 | 56,61 | +0,56% | 1,22% | 4.648.928 |
| 12/05/2003 | 55,56 | 56,39 | 55,11 | 56,30 | +1,32% | 2,30% | 5.045.491 |
| 09/05/2003 | 55,80 | 56,13 | 55,40 | 55,56 | +0,05% | 1,30% | 4.667.687 |
| 08/05/2003 | 55,88 | 55,92 | 55,27 | 55,53 | -0,60% | 1,16% | 4.242.409 |
| 07/05/2003 | 56,20 | 56,44 | 55,57 | 55,87 | -0,59% | 1,54% | 5.473.704 |
| 06/05/2003 | 56,26 | 56,39 | 55,73 | 56,20 | -0,10% | 1,17% | 5.053.666 |
| 05/05/2003 | 56,39 | 56,73 | 55,80 | 56,26 | -0,56% | 1,64% | 4.112.457 |
| 02/05/2003 | 55,15 | 56,97 | 55,15 | 56,57 | +1,35% | 3,29% | 5.753.730 |
| 01/05/2003 | 55,52 | 56,11 | 54,61 | 55,82 | +0,55% | 2,70% | 4.815.246 |
| 30/04/2003 | 54,96 | 56,09 | 54,73 | 55,52 | +1,43% | 2,47% | 9.990.374 |
| 29/04/2003 | 54,48 | 55,11 | 54,10 | 54,73 | +0,28% | 1,86% | 4.678.062 |
| 28/04/2003 | 54,06 | 54,91 | 53,48 | 54,58 | +0,79% | 2,65% | 5.643.690 |
| 25/04/2003 | 55,49 | 55,55 | 53,65 | 54,15 | -2,66% | 3,44% | 7.165.071 |
| 24/04/2003 | 54,93 | 56,13 | 54,82 | 55,63 | +0,28% | 2,38% | 6.733.714 |